Medical Health Cluster

Omicron

Orientaciones actualizadas de la OMS para dar prioridad a las vacunas contra la COVID-19

Las recomendaciones revisadas de vacunación contra la COVID-19 reflejan el impacto de las variantes circulantes de Omicron, así como la inmunidad actual de la población debida a infecciones y vacunaciones previas, según una declaración del Grupo Estratégico Consultivo de Expertos en Inmunización (SAGE), que forma parte de la Organización Mundial […]

Read More

COVID-19 Shot Appears to Reduce Diabetes Risk, Even After Omicron

The increased risk for diabetes following COVID-19 infection has persisted into the Omicron era, but vaccination against SARS-CoV-2 appears to diminish that likelihood, new data suggest. The findings, from more than 20,000 patients in the Cedars-Sinai Health System in Los Angeles, California, suggest that “continued efforts to prevent COVID-19 infection […]

Read More

How Accurate Are Home Antigen Tests for Omicron?

Unsupervised SARS-CoV-2 rapid antigen testing with three commercial kits had 70% to 81% sensitivity during the period when Omicron emerged and became predominant in the Netherlands. Rapid antigen testing for COVID-19 has largely replaced RT-PCR testing in the ambulatory setting, but accuracy data are limited. Dutch investigators performed a prospective […]

Read More

Most People With Omicron Don’t Know They’re Infected

That’s according to a study in JAMA Network Open, which says 56% of people who have the Omicron variant of the coronavirus are unaware of their infection. And it has an upside and a downside, depending on how you look at it, according to Time magazine. “It’s good news, in some ways, since it underscores the […]

Read More

Reino Unido aprueba la primera vacuna contra COVID-19 capaz de proteger de ómicron

Los reguladores de medicamentos británicos se han convertido en los primeros en el mundo en autorizar una versión actualizada de la vacuna contra el coronavirus de Moderna que tiene como objetivo proteger contra el virus original y la variante ómicron. En un comunicado este lunes, la Agencia Reguladora de Medicamentos (EMA) y Atención […]

Read More